Antibiotics to eradicate Streptococcus pyogenes pharyngeal carriage in asymptomatic children and adults: A systematic

Te-Yu Hung1, Linny K Phuong2, Anneke Grobler3

  • 1Victorian Infectious Diseases Service, The Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; Department of Infectious Diseases, The University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia; Department of Paediatrics, Royal Darwin Hospital, Top End Health Service, Northern Territory, Australia.

The Journal of Infection
|February 15, 2024
PubMed

Insights

Oral clindamycin for 10 days appears most effective for eradicating Streptococcus pyogenes carriage. However, evidence is limited, and more research is needed on various antibiotics for S. pyogenes.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Clinical Pharmacology

Background:

  • Streptococcus pyogenes (S. pyogenes) causes diverse illnesses, from mild infections to severe sepsis.
  • Close contacts of S. pyogenes cases face a significantly elevated risk of invasive disease.
  • Management of asymptomatic S. pyogenes carriage and prevention of secondary infections remain inconsistent.

Purpose of the Study:

  • To systematically review antibiotic regimens for eradicating S. pyogenes from the pharynx in asymptomatic individuals.
  • To assess the comparative efficacy of different antibiotic treatments for S. pyogenes carriage.

Main Methods:

  • Systematic review of randomized controlled trials (RCTs) sourced from PubMed, EMBASE, OVID Medline, and Cochrane CENTRAL.
  • Inclusion criteria: asymptomatic participants with S. pyogenes pharyngeal culture positivity, microbiological confirmation (culture +/- PCR), and English language publication.
  • Two independent reviewers performed data extraction and risk of bias assessment.

Main Results:

  • Three RCTs were included from 1166 identified records.
  • Oral clindamycin for 10 days demonstrated superior efficacy compared to benzathine penicillin G with rifampicin, or monotherapy with penicillin or erythromycin.
  • Two RCTs had a high risk of bias; one had a low/some risk of bias.

Conclusions:

  • Limited evidence currently exists for the optimal antibiotic to eradicate pharyngeal S. pyogenes carriage.
  • Future RCTs should investigate penicillin, cephalosporins, rifampicin, macrolides (e.g., azithromycin), and clindamycin.

Related Concept Videos

Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
666
Chronic Pharyngitis01:23

Chronic Pharyngitis

Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
2.1K
Tonsillitis I: Introduction01:30

Tonsillitis I: Introduction

Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat.
Etiology
Three primary contributing factors have been identified.
251
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
403
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
111